Inhibition of BMP signaling in P-Cadherin positive hair progenitor cells leads to trichofolliculoma-like hair follicle neoplasias

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Kan, Lixin ^a   Liu, Yijie ^a   McGuire, Tammy L ^a   Bonaguidi, Michael A ^b   Kessler, John A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bone morphogenetic protein (BMP); Nse Noggin; Transgenic Mice; trichofolliculoma

Indexed keywords

BONE MORPHOGENETIC PROTEIN; HERMES ANTIGEN; NEURON SPECIFIC ENOLASE; NOGGIN; P CADHERIN; UVOMORULIN; CADHERIN; CARRIER PROTEIN; CD44 PROTEIN, MOUSE; NOGGIN PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; HAIR FOLLICLE; HAIR GROWTH; HAIR ROOT; HOMEOSTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL; TRANSGENIC MOUSE; TRICHOEPITHELIOMA; ANIMAL; BASAL CELL CARCINOMA; DISEASE MODEL; DRUG ANTAGONISM; FOLLICLE CYST; GENETICS; HAIR DISEASE; METABOLISM; PATHOLOGY; SKIN TUMOR;

MUS; MUS MUSCULUS;

ANIMALS; ANTIGENS, CD44; BONE MORPHOGENETIC PROTEINS; CADHERINS; CARRIER PROTEINS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; FOLLICULAR CYST; HAIR DISEASES; HAIR FOLLICLE; MICE; MICE, TRANSGENIC; NEOPLASMS, BASAL CELL; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; STEM CELLS;

EID: 83355161469     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-92     Document Type: Article

References (36)

1. Building epithelial tissues from skin stem cells. Fuchs E, Nowak JA, Cold Spring Harb Symp Quant Biol 2008 73 333 350 10.1101/sqb.2008.73.032 19022769
2. Wnt signaling, lgr5, and stem cells in the intestine and skin. Haegebarth A, Clevers H, Am J Pathol 2009 174 715 721 10.2353/ajpath.2009.080758 19197002
3. Emerging role of Notch signaling in epidermal differentiation and skin cancer. Panelos J, Massi D, Cancer Biol Ther 2009 8 1986 1993 10.4161/cbt.8.21.9921 19783903
4. FGF-regulated BMP signaling is required for eyelid closure and to specify conjunctival epithelial cell fate. Huang J, Dattilo LK, Rajagopal R, Liu Y, Kaartinen V, Mishina Y, Deng CX, Umans L, Zwijsen A, Roberts AB, Beebe DC, Development 2009 136 1741 1750 10.1242/dev.034082 19369394
5. Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies. Mimeault M, Batra SK, Pharmacol Rev 2010 62 497 524 10.1124/pr.109.002329 20716670
6. BMP signaling in the control of skin development and hair follicle growth. Botchkarev VA, Sharov AA, Differentiation 2004 72 512 526 10.1111/j.1432-0436.2004.07209005.x 15617562 (Pubitemid 41702106)
7. From developmental disorder to heritable cancer: it's all in the BMP/TGF-beta family. Waite KA, Eng C, Nat Rev Genet 2003 4 763 773 14526373 (Pubitemid 37193268)
8. Bone morphogenetic proteins and their antagonists in skin and hair follicle biology. Botchkarev VA, J Invest Dermatol 2003 120 36 47 10.1046/j.1523-1747.2003.12002.x 12535196 (Pubitemid 36124035)
9. Generation of a Bmp2 conditional null allele. Ma L, Martin JF, Genesis 2005 42 203 206 10.1002/gene.20132 15986484 (Pubitemid 41099679)
10. Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Lawson KA, Dunn NR, Roelen BA, Zeinstra LM, Davis AM, Wright CV, Korving JP, Hogan BL, Genes Dev 1999 13 424 436 10.1101/gad.13.4.424 10049358 (Pubitemid 29108758)
11. Transgenic mice expressing beta-galactosidase in mature neurons under neuron-specific enolase promoter control. Forss-Petter S, Danielson PE, Catsicas S, Battenberg E, Price J, Nerenberg M, Sutcliffe JG, Neuron 1990 5 187 197 10.1016/0896-6273(90)90308-3 2116814 (Pubitemid 20262697)
12. A revaluation of folliculosebaceous cystic hamartoma: the histopathological and immunohistochemical features. Misago N, Kimura T, Toda S, Mori T, Narisawa Y, Am J Dermatopathol 2010 32 154 161 10.1097/DAD. 0b013e3181a9de8c 19755908
13. Sebaceous trichofolliculoma. Plewig G, J Cutan Pathol 1980 7 394 403 10.1111/j.1600-0560.1980.tb01213.x 7451702 (Pubitemid 11197241)
14. De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Gat U, DasGupta R, Degenstein L, Fuchs E, Cell 1998 95 605 614 10.1016/S0092-8674(00)81631-1 9845363 (Pubitemid 28544122)
15. Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment. Gomes WA, Mehler MF, Kessler JA, Dev Biol 2003 255 164 177 10.1016/S0012-1606(02)00037-4 12618141 (Pubitemid 36287148)
16. Bone morphogenetic protein signaling regulates postnatal hair follicle differentiation and cycling. Guha U, Mecklenburg L, Cowin P, Kan L, O'Guin WM, D'Vizio D, Pestell RG, Paus R, Kessler JA, Am J Pathol 2004 165 729 740 10.1016/S0002-9440(10)63336-6 15331398 (Pubitemid 39129281)
17. Dysregulation of local stem/progenitor cells as a common cellular mechanism for heterotopic ossification. Kan L, Liu Y, McGuire TL, Berger DM, Awatramani RB, Dymecki SM, Kessler JA, Stem Cells 2009 27 150 156 10.1634/stemcells.2008-0576 18832590
18. Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Devlin RD, Du Z, Pereira RC, Kimble RB, Economides AN, Jorgetti V, Canalis E, Endocrinology 2003 144 1972 1978 10.1210/en.2002-220918 12697704 (Pubitemid 36543336)
19. Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation. Sharov AA, Weiner L, Sharova TY, Siebenhaar F, Atoyan R, Reginato AM, McNamara CA, Funa K, Gilchrest BA, Brissette JL, Botchkarev VA, EMBO J 2003 22 2992 3003 10.1093/emboj/cdg291 12805214 (Pubitemid 36758620)
20. Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. Wu XB, Li Y, Schneider A, Yu W, Rajendren G, Iqbal J, Yamamoto M, Alam M, Brunet LJ, Blair HC, et al. J Clin Invest 2003 112 924 934 12975477 (Pubitemid 38063750)
21. Target-derived BMP signaling limits sensory neuron number and the extent of peripheral innervation in vivo. Guha U, Gomes WA, Samanta J, Gupta M, Rice FL, Kessler JA, Development 2004 131 1175 1186 10.1242/dev.01013 14973275 (Pubitemid 38380470)
22. P-cadherin is a p63 target gene with a crucial role in the developing human limb bud and hair follicle. Shimomura Y, Wajid M, Shapiro L, Christiano AM, Development 2008 135 743 753 10.1242/dev.006718 18199584 (Pubitemid 351405027)
23. Links between signal transduction, transcription and adhesion in epithelial bud development. Jamora C, DasGupta R, Kocieniewski P, Fuchs E, Nature 2003 422 317 322 10.1038/nature01458 12646922 (Pubitemid 36378359)
24. CD44, a therapeutic target for metastasising tumours. Orian-Rousseau V, Eur J Cancer 2010 46 1271 1277 10.1016/j.ejca.2010.02.024 20303742
25. Developmental changes in progenitor cell responsiveness to cytokines. Zhu G, Mehler MF, Mabie PC, Kessler JA, J Neurosci Res 1999 56 131 145 10.1002/(SICI)1097-4547(19990415)56:2<131::AID-JNR3>3.0.CO;2-I 10494102 (Pubitemid 29201052)
26. Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA. Kobielak K, Pasolli HA, Alonso L, Polak L, Fuchs E, J Cell Biol 2003 163 609 623 10.1083/jcb.200309042 14610062 (Pubitemid 37429873)
27. Essential roles of BMPR-IA signaling in differentiation and growth of hair follicles and in skin tumorigenesis. Ming Kwan K, Li AG, Wang XJ, Wurst W, Behringer RR, Genesis 2004 39 10 25 10.1002/gene.20021 15124223 (Pubitemid 38738012)
28. The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. Howe JR, Sayed MG, Ahmed AF, Ringold J, Larsen-Haidle J, Merg A, Mitros FA, Vaccaro CA, Petersen GM, Giardiello FM, et al. J Med Genet 2004 41 484 491 10.1136/jmg.2004.018598 15235019 (Pubitemid 38932108)
29. Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice. Li W, Qiao W, Chen L, Xu X, Yang X, Li D, Li C, Brodie SG, Meguid MM, Hennighausen L, Deng CX, Development 2003 130 6143 6153 10.1242/dev.00820 14597578 (Pubitemid 38008814)
30. Chemical skin carcinogenesis is prevented in mice by the induced expression of a TGF-beta related transgene. Blessing M, Nanney LB, King LE, Hogan BL, Teratog Carcinog Mutagen 1995 15 11 21 10.1002/tcm.1770150103 7604388 (Pubitemid 126684648)
31. The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients. Bieniasz M, Oszajca K, Eusebio M, Kordiak J, Bartkowiak J, Szemraj J, Lung Cancer 2009 66 319 326 10.1016/j.lungcan.2009.02.020 19324447
32. Overexpression of bone morphogenic protein (BMP)-4 mRNA in gastric cancer cell lines of poorly differentiated type. Katoh M, Terada M, J Gastroenterol 1996 31 137 139 10.1007/BF01211202 8808444 (Pubitemid 26048486)
33. Overexpression of BMP-2/4, -5 and BMPR-IA associated with malignancy of oral epithelium. Jin Y, Tipoe GL, Liong EC, Lau TY, Fung PC, Leung KM, Oral Oncol 2001 37 225 233 10.1016/S1368-8375(00)00087-7 11287276 (Pubitemid 32245846)
34. Inhibition of Bmp signaling affects growth and differentiation in the anagen hair follicle. Kulessa H, Turk G, Hogan BL, EMBO J 2000 19 6664 6674 10.1093/emboj/19.24.6664 11118201 (Pubitemid 32011659)
35. Morpho-regulation of ectodermal organs: integument pathology and phenotypic variations in K14-Noggin engineered mice through modulation of bone morphogenic protein pathway. Plikus M, Wang WP, Liu J, Wang X, Jiang TX, Chuong CM, Am J Pathol 2004 164 1099 1114 10.1016/S0002-9440(10)63197-5 14982863 (Pubitemid 38235491)
36. Bone morphogenetic protein antagonist noggin promotes skin tumorigenesis via stimulation of the Wnt and Shh signaling pathways. Sharov AA, Mardaryev AN, Sharova TY, Grachtchouk M, Atoyan R, Byers HR, Seykora JT, Overbeek P, Dlugosz A, Botchkarev VA, Am J Pathol 2009 175 1303 1314 10.2353/ajpath.2009.090163 19700758